TI
Toronto Innovation Acceleration Partners
Venture CapitalActiveToronto Innovation Acceleration Partners is a member-driven not-for-profit organization
49
Investments
5
Exits
$200M
AUM
10.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Toronto Innovation Acceleration Partners.
Investment Thesis & Strategy
TIAP invests in various stages of information technology, property management, and venture capital companies, focusing on member-driven, not-for-profit organizations.
Investment Activity
Deals per year over the last 6 years
2
20171
20182
20190
20201
20216
2022Portfolio Companies
Selected investments from their portfolio of 49 companies
R
Reaction Biology
Biotech · Growth, 2022
B
Bright
Healthcare · Series A, 2022
e
eSight
Healthcare · Growth, 2022
N
Nanology Labs
Biotech · Seed, 2022
I
Integrative AI
AI/ML · Series A, 2022
C
CellCarta
Biotech · Growth, 2022
N
NuraLogix
Healthcare · Series A, 2021
W
Winterlight Labs
Healthcare · Series A, 2019
B
BlueDot
Healthcare · Series B, 2019
C
Cyclica
Biotech · Series B, 2018
D
Deep Genomics
Biotech · Series B, 2017
A
Ada
Healthcare · Series B, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
Deep GenomicsAcquisition2024—
BlueDotAcquisition2023—
IntegracareAcquisition2022—
KiiteAcquisition2022—
RubikloudAcquisition2018—
Frequently Asked Questions
Toronto Innovation Acceleration Partners focuses on Series A, Series B, Series C+ stage investments.